Page 3 - Nasdaq Path News Today

UiPath (NASDAQ:PATH – Get Rating) had its price target lowered by investment analysts at Canaccord Genuity Group from $55.00 to $30.00 in a report released on Thursday, Benzinga reports. The firm presently has a “hold” rating on the healthcare company’s stock. Canaccord Genuity Group’s price objective points to a potential upside of 27.33% from the […]

Signaturefd LLC raised its position in shares of UiPath Inc. (NASDAQ:PATH – Get Rating) by 564.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,560 shares of the healthcare company’s stock after buying an additional 3,024 shares during the quarter. Signaturefd LLC’s […]

Kingfisher Capital LLC acquired a new position in UiPath Inc. (NASDAQ:PATH – Get Rating) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 25,489 shares of the healthcare company’s stock, valued at approximately $1,099,000. Several other institutional investors have also recently modified their holdings of the company. Sumitomo Mitsui Trust Holdings Inc. lifted […]

National Bank of Canada FI bought a new position in shares of UiPath Inc. (NASDAQ:PATH – Get Rating) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 380,800 shares of the healthcare company’s stock, valued at approximately $16,425,000. Other hedge funds and other institutional investors have also modified their holdings of the company. […]

Kestra Private Wealth Services LLC bought a new position in shares of UiPath Inc. (NASDAQ:PATH – Get Rating) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 12,840 shares of the healthcare company’s stock, valued at approximately $554,000. Several other […]

Royal London Asset Management Ltd. purchased a new stake in UiPath Inc. (NASDAQ:PATH – Get Rating) during the 4th quarter, Holdings Channel.com reports. The fund purchased 75,455 shares of the healthcare company’s stock, valued at approximately $3,256,000. Other institutional investors also recently made changes to their positions in the company. Carroll Financial Associates Inc. purchased […]

UiPath (NASDAQ:PATH – Get Rating) had its price target cut by equities research analysts at Wells Fargo & Company from $60.00 to $45.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has an “overweight” rating on the healthcare company’s stock. Wells Fargo & Company‘s target price points to a potential upside of […]

Cubist Systematic Strategies LLC decreased its position in shares of UiPath Inc. (NASDAQ:PATH – Get Rating) by 83.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,608 shares of the healthcare company’s stock after selling 47,152 shares during the period. Cubist […]